Reaction
Acute Hepatitis B reporting signals
As of the last recalculation, Acute Hepatitis B appears in 331 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is ENTECAVIR (PRR 96.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Entecavir | 17 | 96.5 | 96.6 |
| Cabotegravir | 9 | 72.0 | 72.1 |
| Tenofovir Disoproxil Fumarate Tablets | 9 | 67.3 | 67.4 |
| Lamivudine Oral | 14 | 36.3 | 36.3 |
| Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate | 9 | 32.1 | 32.1 |
| Vincristine Sulfate | 13 | 29.0 | 29.0 |
| Dolutegravir Sodium | 4 | 28.2 | 28.2 |
| Obinutuzumab | 6 | 23.3 | 23.3 |
| Emtricitabine And Tenofovir Alafenamide | 4 | 22.4 | 22.5 |
| Tenofovir Disoproxil Fumarate | 11 | 21.6 | 21.6 |